[1]Barbolina MV. Molecular mechanisms regulating organspecific metastases in epithelial ovarian carcinoma\[J\]. Cancers, 2018, 10(11): 444-461.
[2]De P, Aske JC, Dey N. Rac1 takes the lead in solid tumors\[J\]. Cells, 2019, 8(5): 382-399.
[3]Svensmark JH, Brakebusch C. Rho GTPase in cancer: friend or foe? \[J\]. Oncogene, 2019, 38(50): 7447-7456.
[4]Leng R, Liao G, Wang H, et al. Rac1 expression in epithelial ovarian cancer: effect on cell EMT and clinical outcome\[J\]. Med Oncol, 2015, 32(2): 329-340.
[5]Loret N, Denys H, Tummers P, et al. The role of epithelialtomesenchymal plasticity in ovarian cancer progression and therapy resistance\[J\]. Cancers, 2019, 11(6): 838-859.
[6]Lee JF, Zeng Q, Ozaki H, et al. Dual roles of tight junctionassociated protein, zonula occludens1, in sphingosine 1phosphatemediated endothelial chemotaxis and barrier integrity\[J\]. J Biol Chem, 2006, 281(39): 29190-29200.
[7]Hudson L, Gillette J, Kang H, et al. Ovarian tumor microenvironment signaling: convergence on the Rac1 GTPase\[J\]. Cancers, 2018, 10(10):358-383.
[8]Chen B, Chou HT, Brautigam CA, et al. Rac1 GTPase activates the WAVE regulatory complex through two distinct binding sites\[J\]. ELife, 2017, 6: e29795.
[9]Byrne KM, Monsefi N, Dawson JC, et al. Bistability in the Rac1, PAK, and RhoA signaling network drives actin cytoskeleton dynamics and cell motility switches\[J\]. Cell Syst, 2016, 2(1): 38-48.
[10]Fang D, Chen H, Zhu JY, et al. Epithelialmesenchymal transition of ovarian cancer cells is sustained by Rac1 through simultaneous activation of MEK1/2 and Src signaling pathways\[J\]. Oncogene, 2017, 36(11): 1546-1558.
[11]Zhou G, Peng F, Zhong Y, et al. Rhein suppresses matrix metalloproteinase production by regulating the Rac1/ROS/MAPK/AP1 pathway in human ovarian carcinoma cells\[J\]. Int J Oncol, 2017, 50(3): 933-941.
[12]GonzalezVillasana V, FuentesMattei E, Ivan C, et al. Rac1/Pak1/p38/MMP2 axis regulates angiogenesis in ovarian cancer\[J\]. Clin Cancer Res, 2015, 21(9): 2127-2137.
[13]Babkair H, Yamazaki M, Uddin MS, et al. Aberrant expression of the tight junction molecules claudin1 and zonula occludens1 mediates cell growth and invasion in oral squamous cell carcinoma\[J\]. Hum Pathol, 2016, 57: 51-60.
[14]徐静, 王绪麟, 李思涵, 等. 紧密连接蛋白ZO1在人乳腺癌中的表达及意义\[J\]. 广东医学, 2016, 37(20): 3059-3061.
[15]Kaihara T, Kusaka T, Nishi M, et al. Dedifferentiation and decreased expression of adhesion molecules, Ecadherin and TJP1, in colorectal cancer are closely related to liver metastasis\[J\]. J Exp Clin Cancer Res, 2003, 22(1): 117-123.
[16]Nagai T, Arao T, Nishio K, et al. Impact of tight junction protein TJP1 and TWIST expression on postoperative survival of patients with hepatocellular carcinoma\[J\]. Dig Dis, 2016, 34(6): 702-707.
[17]Yan M, Yang X, Shen R, et al. miR146b promotes cell proliferation and increases chemosensitivity, but attenuates cell migration and invasion via FBXL10 in ovarian cancer\[J\]. Cell Death Dis, 2018, 9(11): 1123-1139.
[18]Knezevic I, Predescu SA, Neamu RF, et al. Tiam1 and Rac1 are required for plateletactivating factorinduced endothelial junctional disassembly and increase in vascular permeability\[J\]. J Biol Chem, 2009, 284(8): 5381-5394.
[19]Kleeff J, Shi X, Bode HP, et al. Altered expression and localization of the tight junction protein TJP1 in primary and metastatic pancreatic cancer\[J\]. Pancreas, 2001, 23(3): 259-265.
|